Clinical Trials
1
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Efficacy Assessment of a Novel 3D Cartography-based Targeted Focal Microwave Therapy in Men With Localized Intermediate-risk Prostate Cancer
- Conditions
- Prostate Cancer
- First Posted Date
- 2020-10-09
- Last Posted Date
- 2021-08-06
- Lead Sponsor
- Koelis
- Target Recruit Count
- 65
- Registration Number
- NCT04582656
- Locations
- 🇧🇪
Institut Jules Bordet, Brussels, Belgium
🇫🇷Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
🇫🇷American Hospital of Paris, Neuilly-sur-Seine, France
News
Koelis and Bot Image Partner to Enhance Prostate Cancer Detection with AI-Powered Fusion Biopsy Technology
Koelis has announced a strategic partnership with Bot Image to integrate ProstatID™, an FDA-cleared AI-based lesion detection software, with their Trinity® MRI-fusion guidance system for improved prostate cancer diagnostics.
VIOLETTE Trial Shows Promise for Precise Microwave Ablation in Prostate Cancer
Interim results from the VIOLETTE trial indicate that organ-based tracking fusion (OBT-Fusion) technology allows for precise planning in targeted microwave ablation of prostate cancer.
KOELIS Announces Positive Interim Results from VIOLETTE Trial on Targeted Microwave Ablation for Prostate Cancer
The VIOLETTE trial, a multicenter Phase II study, evaluates KOELIS' OBT-Fusion technology for targeted microwave ablation (TMA) in prostate cancer.